Hidden behind the nearly doubling of the user fee to redeem a priority review voucher was a substantial decline in novel application assessments and an increase in assessment costs.
US FDA’s New Voucher Fee Reveals Standard, Priority Review Cost Spike
The number of standard and priority reviews also decreased significantly in FY 2023 compared to the previous year, which caused the fee for redeeming a voucher to rise.
